Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition and development of novel therapeutics for the treatment of cancer.
NASDAQ: PBYI5.17+0.07 ( 1.37% )Vol: 248,185 ... Annual Reports & Proxies · Analyst Coverage ... Quick Links. SEC Filings · Investor FAQs · Information Request Form ...
People also ask
Who is the parent company of Puma biotechnology?
What are the results of Puma biotechnology?
Who is the CEO of Puma biotechnology?
How do I contact Puma biotechnology?
$5.51
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Mar 2, 2024 · Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript February 29, 2024 Puma Biotechnology, Inc. misses on earnings ...
Discover real-time Puma Biotechnology Inc Common Stock (PBYI) stock prices, quotes, historical data, news, and Insights for informed trading and investment ...
Find the latest Puma Biotechnology, Inc. (PBYI) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Puma Biotechnology Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View PBYI financial statements in full.
Rating
(2,975)
Puma Biotechnology (PBYI) will release its next earnings report on May 2, 2024. In the last quarter Puma Biotechnology reported $0.3 EPS in relation to ...
PBYI, Puma Biotechnology - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines.
Puma Biotechnology, Inc. (US:PBYI) has 136 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC) ...